ArticleBiomaterials research2023

Controlled release of Clenbuterol from a hydroxyapatite carrier for the treatment of Alzheimer's Disease.

Yi-Wen Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.